Vancomycin: A History

Citations Over TimeTop 10% of 2005 papers

Abstract

Vancomycin became available for clinical use >50 years ago but was soon discarded in favor of other antibiotics that were deemed to be more efficacious and less toxic. The advent of pseudomembranous enterocolitis, coupled with the spread of methicillin-resistant Staphylococcus aureus, led to a resurgence in the use of vancomycin. Almost immediately, concerns arose with regard to its therapeutic utility. In addition, resistance to vancomycin developed, first in enterococci and later in staphylococci. Several types of resistance have now been identified, each with a unique effect on infections treated with vancomycin. Recent studies have rekindled interest in the best way to administer the antibiotic. The findings of future studies may result in a return to measuring levels of vancomycin in serum, to assure a successful therapeutic outcome.

Related Papers

• → Does Intrawound Vancomycin Application During Spine Surgery Create Vancomycin-Resistant Organism?(2017)72 cited
• → Vancomycin Revisited: A Reappraisal of Clinical Use(2008)38 cited
• → An Evaluation of a Kit Applied Bioluminescence Method for the Detection of Staphylococcus aureus.(1999)
• → Επιπολασμός και αποικισμός του Staphylococcus aureus στα οικόσιτα και παραγωγικά ζώα, καθώς και στους εμπλεκόμενους με τη φροντίδα τους(2020)
• → Analysis of Antimicrobial Agents' Effect on Activity of Acute Respiratory Disease Causal Organism Staphylococcus Aureus(2022)